



Facet Biotech Corporation: Facet Biotech Announces Participation at Upcoming Investor Conferences
REDWOOD CITY, CA--(Marketwire - September 2, 2009) - Facet Biotech Corporation (
-- The Thomas Weisel Partners Healthcare Conference in Boston on Thursday, September 10, 2009 at 4:25 p.m., Eastern Time. -- The UBS Global Life Sciences Conference in New York on Wednesday, September 23, 2009 at 8:30 a.m., Eastern Time.
Live webcasts of both presentations will be available through the Facet website at [ www.facetbiotech.com ]. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at [ www.facetbiotech.com ] starting approximately one hour after completion of the webcast.
About Facet Biotech
Facet Biotech is a biotechnology company dedicated to advancing its pipeline of five clinical-stage products, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.
NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks of Facet Biotech Corporation.